Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the prospective neoadjuvant breast registry symphony trial (NBRST). Beitsch, Gittleman, and Whitworth et al - Ann Surg Onc. 2014 Aug.

Whitworth PW, Beitsch P, Gittleman M et al. Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). Ann Surg Oncol. 2014 Oct. 21(10): 3261-3267. 

Project details

Tags: Genetics, NeoAdjuvant, Featured

Related projects

Vivamus molestie gravida turpis